Effect of Shenfu Injection on immunoregulation and inflammatory factors in septic mice
ZHAO Fengli1 XIAN Shaoxiang2 LUO Yuanyuan1 WANG Yixin3 XU Yunsheng1 LIN Xinfeng1
1.Department of Critical Care Medicine, the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Province, Guangzhou 510405, China; 2.Department of Cardiology, the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Province, Guangzhou 510405, China; 3.Department of Acupuncture, the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Province, Guangzhou 510405, China
Abstract：Objective To investigate the effects of Shenfu Injection on immuno regulation and inflammatory factors in septic mice. Methods A total of 120 10-week-old SPF male C57BL/6 mice were selected and divided into control group, sham operation group, septic model group and Shenfu Injection treatment group according to random number table method, with 30 rats in each group. A septic mice model was prepared by cecal ligation and perforation. The control group, sham-operated group and sepsis model group were given intraperitoneal injection of saline [4 mL/(kg·BW) for 3 days] respectively on the first day after operation, and Shenfu Injection group was given intraperitoneal injection of Shenfu Injection [4 mL/(kg·BW) for 3 days] at the same time. T lymphocyte subsets in each group were detected by enzyme-linked immunosorbent assay, hematoxylin-eosin staining was used to evaluate organ pathological damage and inflammatory cell infiltration. Results Compared with the control group, the levels of interleukin-4 (IL-4), IL-17, interferon γ (IFN-γ), IL-10 and IFN-γ/IL-4, IL-10/IL-17 in sham operation group had no significant difference (P > 0.05). Compared with sham-operated group, the levels of IFN-γ and IL-10 in sepsis model group were significantly decreased, IL-4 and IL-17 were significantly increased, and IFN-γ/IL-4 and IL-10/IL-17 were significantly decreased, the differences were statistically significant (P < 0.05), and its pathological damage of heart, lung and kidney was serious, and the infiltration of inflammatory cells was increased (P < 0.05). Compared with sepsis model group, the levels of IFN-γ and IL-10 increased, IL-4 and IL-17 decreased, IFN-γ/IL-4 and IL-10/IL-17 increased in Shenfu injection treatment group, but were lower than those in control group, the difference were statistically significant (P < 0.05), and its pathological damage of organs was relieved and the infiltration of inflammatory cells was alleviated (all P < 0.05). Conclusion Shenfu Injection can regulate the immune system of sepsis mice, inhibit inflammation and alleviate organ damage.
[1] Singer M，Deutschman CS，Seymour CW，et al. The Third International Consensus Definitions for Sepsis and Septic Shock （Sepsis-3） [J]. JAMA，2016，315（8）：801-810.
[2] Martínez ML，Ferrer R，Torrents E，et al. Impact of Source Control in Patients With Severe Sepsis and Septic Shock [J]. Crit Care Med，2017，45（1）：11-19.
[3] Miroslav V，Nevena G，Denis B，et al. The relationship between the immune system and oral manifestations of inflammatory and oral manifestations of inflammatory bowel disease [J]. Cent Eur J Immunol，2016，41（3）：302-310.
[4] 陈如杰，张明，潘利伟，等.参附注射液对感染性体克患者炎症反应及免疫功能影响的临床对照研究[J].中华中医药学刊，2015，33（10）：2461- 2464.
[5] Askim ?魡，Moser F，Gustad LT，et al. Poor performance of quick-SOFA （qSOFA） score in predicting severe sepsis and mortality - a prospective study of patients admitted with infection to the emergency department [J]. Scand J Trauma Resusc Emerg Med，2017，25（1）：56.
[6] Dorsett M，Kroll M，Smith C S，et al. qSOFA Has Poor Sensitivity for Prehospital Identification of Severe Sepsis and Septic Shock [J]. Prehosp Emerg Care，2017，21（4）：489-497.
[7] Caironi P，Masson S，Mauri T，et al. Pentraxin 3 in patients with severe sepsis or shock： the ALBIOS trial [J]. Euro J Clin Invest，2017，47（1）：73-83.
[8] 姚咏明，盛志勇.Janus激酶/信号转导子和转录激活因子通路与创伤脓毒症的关系[J].解放军医学杂志，2004，29（1）：27-29.
[9] Iskander KN，Osuchowski MF，Stearns-Kurosawa DJ，et al. Sepsis：multiple abnormalities，heterogeneous responses，and evolving understanding [J]. Physiol Rev，2013，93（3）：1247-1288.
[10] 姚咏明，张立天，陆家齐，等.脓毒症大鼠肾组织高迁移率族蛋白对肿瘤坏死因子表达的影响[J].解放军医学杂志，2002，27：757-759.
[11] Wong HR，Cvijanovich NZ，Anas N，et al. Developing a clinically feasible personalized medicine approach to pediatric septic shock [J]. Am J Respir Crit Care Med. 2015， 191（3）：309-315.
[12] 易凡，尚玉强，李炳，等.参附注射液对心肌缺血再灌注损伤模型大鼠的保护作用[J].中国老年学杂志，2017， 39（1）： 58-61.
[13] 马建生，杨晓丽.参附注射液对脓毒性休克患者内皮细胞功能的影响[J].中国老年学杂志，2016，7（33）：3244-3215.
[14] 陈如杰，张明，潘利伟，等.参附注射液对感染性休克患者炎症反应及免疫功能影响的临床对照研究[J].中华中医药学刊，2015，33（10）：2161.
[15] 傅声武.参附注射液对脓毒症休克血流动力学的影响[J].医学临床与教育，2011，12（6）：681-682.
[16] 黄梅青，朱燕华，赵世元.石仙桃多糖对肺炎支原体感染模型小鼠Th1/Th2细胞因子表达的影响[J]中国医药导报，2018，15（8）：15-19.
[17] 文丽丹，杨海玉.Th17淋巴细胞与风湿免疫性疾病关系的研究进展[J]中国医药导报，2017，14（26）：49-52.
[18] 程涛，伍伟玲，黄河.肺结核患者Th1/Th2/Treg/Th17免疫应答的临床研究[J]中国医药导报，2017，14（26）：109-112.
[19] 曾清，陆海颂，程纬民，等.参萸补血方对再生障碍性贫血模型小鼠Th17细胞及其相关因子IL-6、IL-17及IL-23表达水平的影响[J].中国医药导报，2018，15（12）：13-16.
[20] 孙淑荣，刘业清，王荣辉.参附注射液对严重脓毒血症和脓毒性休克早期复苏的干预研究[J].中国中医急症，2007，16（10）：1214-1215.
2019, Vol. 16 
京公网安备 11010502046598号